Umut Demirci

8PUBLICATIONS
45CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 26, 2026
Prognostic Value of the Inflammatory Burden Index (IBI) in Metastatic Urothelial Carcinoma Prior to First-Line Therapy.

|Jul 24, 2025
Evaluation of implementation of evolving practice patterns in the first-line treatment of patients with metastatic non-small cell lung cancer in Turkiye (ESTIMATE): a national, multicenter, retrospective, real-world evidence study.

Mehmet Ali Nahit Sendur, Nuri Karadurmus, Irfan Cicin

|Oct 16, 2024
Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group Study.

Ebru Karci, Ahmet Bilici, Buket Bayram

|Nov 28, 2023
Genetic testing and counseling challenges in personalized breast cancer care: review article with insights from Türkiye.

Irfan Cicin, Nuri Karadurmus, Ahmet Bilici

|Jul 14, 2023
Safety of lorlatinib in ALK-positive non-small-cell lung cancer and management of central nervous system adverse events.

Saadettin Kilickap, Sertac Ak, Oldac U Dursun

|Nov 02, 2021
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database.

Emre Yekedüz, İsmail Ertürk, Deniz Tural

Pageof 2

Frequent Collaborators

4 joint publications

Nuri Karadurmuş

3 joint publications

Mehmet An Sendur

3 joint publications

İrfan Çiçin

2 joint publications

Ismail Selvi